Mutations of Hepatitis C Virus 1b NS5A 2209-2248 amino acid sequence is not a predictive factor for response to interferon-alpha therapy and development of Hepatocellular Carcinoma

Genetic changes between codons 2209 and 2248 of NS5A of genotype 1b hepatitis C virus (HCV-1b) have been reported to be associated with the sensitivity to interferon-alpha (IFN-α). The present study was performed to analyze such relationship in Korean patients with chronic hepatitis C and HCV-1b (n=19), including 12 chronic hepatitis C patients treated with IFN-α, 3 chronic hepatitis C patients without treatment as controls, and 4 patients with hepatocellular carcinoma (HCC). Two serum samples, before and after the treatment, were analyzed for the mutations by reverse transcription-polymerase chain reaction, cloning and sequencing. The mutations were identified in 32% (6/19), including five intermediate type (1-3 mutations) and one mutant type (4 or more). In 12 patients treated with IFN-α, the number of amino acid substitutions in NS5A_2209-2248 was not associated with outcome of the treatment. Two HCV isolates with NS5A_2209-2248 mutations from HCC patients were intermediate type. These results do not support that the NSSA_2209-2248 determines interferon sensitivity of HCV-1b and that the mutations is associated with development of HCC.